Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Arrakis37on Jun 07, 2018 9:08am
238 Views
Post# 28138247

RE:RE:Summary of past 6 weeks

RE:RE:Summary of past 6 weeks
Rapid, it's more complex than it appear, I understand many of the aspects of a startup.  One of them is strategic.  Big pharmas play dirty and are so powerful than when a tiny little player like PLI want to be a big boy, they don't let that company grow without reaction.

It obvious that PLI was attacked to be weaken by people who work behind the curtains.  Is it the pharmas or only shorters who had privilegied informations ? I don't know.  When so much money is at stake, it's funny to see puzzling things happened.  

To me, it makes no sense that a so incredible science can be punished like that.  Compare 5 years ago and now in term of progress : that doesn't compute.  We lost 500M$ of market cap for 1 year delay by FDA at 120M$.  Ridiculous.  So I think management do what they can with what they have. And they're definetly not good at chess... 
 
As for the ignomenious paycheck of Pierre, if I was him, I sould be shameful.  Normally, you eat the dessert AFTER the meal.  Same thing about Fred Dumais, his way to manage the crisis is despicable, unworthy of his position.  So no, I definitely don't give them a "free pass". But as I said, we have no power.

Have a good day,
Arrakis
Bullboard Posts